Migraine and Eptinezumab

Our next educational dinner opportunity is sponsored by Lundbeck a biopharmaceutical company that focuses on brain diseases. They will be discussing treatment with Eptinezumab for migraine prevention.

If the sign up becomes full, you are invited to put your name on the waiting list for an available spot. Please if you sign up and are unable to attend, cancel your registration to make room for another individual.

We look forward to seeing you all!